These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32513669)

  • 21. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
    Smith LC; George O
    Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobehavioral mechanisms of nicotine action: role in the initiation and maintenance of tobacco dependence.
    Rosecrans JA; Karan LD
    J Subst Abuse Treat; 1993; 10(2):161-70. PubMed ID: 8510190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine and opioid co-dependence: Findings from bench research to clinical trials.
    Custodio L; Malone S; Bardo MT; Turner JR
    Neurosci Biobehav Rev; 2022 Mar; 134():104507. PubMed ID: 34968525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.
    Higgins ST; Bergeria CL; Davis DR; Streck JM; Villanti AC; Hughes JR; Sigmon SC; Tidey JW; Heil SH; Gaalema DE; Stitzer ML; Priest JS; Skelly JM; Reed DD; Bunn JY; Tromblee MA; Arger CA; Miller ME
    Prev Med; 2018 Dec; 117():15-23. PubMed ID: 29626557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature.
    DiFranza JR; Wellman RJ
    Nicotine Tob Res; 2005 Feb; 7(1):9-26. PubMed ID: 15804674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.
    Hall BJ; Wells C; Allenby C; Lin MY; Hao I; Marshall L; Rose JE; Levin ED
    Pharmacol Biochem Behav; 2014 May; 120():103-8. PubMed ID: 24560911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of nicotine addiction: present therapeutic options and pipeline developments.
    Polosa R; Benowitz NL
    Trends Pharmacol Sci; 2011 May; 32(5):281-9. PubMed ID: 21256603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette smoking and nicotine addiction.
    Benowitz NL
    Med Clin North Am; 1992 Mar; 76(2):415-37. PubMed ID: 1548969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal Models to Investigate the Impact of Flavors on Nicotine Addiction and Dependence.
    Bagdas D; Kebede N; Zepei AM; Harris L; Minanov K; Picciotto MR; Addy NA
    Curr Neuropharmacol; 2022; 20(11):2175-2201. PubMed ID: 35611777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rodent models of nicotine withdrawal syndrome.
    Malin DH; Goyarzu P
    Handb Exp Pharmacol; 2009; (192):401-34. PubMed ID: 19184657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous opioid system: a promising target for future smoking cessation medications.
    Norman H; D'Souza MS
    Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans.
    Perkins KA; Karelitz JL; Boldry MC
    Front Psychiatry; 2017; 8():65. PubMed ID: 28507522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence.
    Novick AM; Duffy KA; Johnson RL; Sammel MD; Cao W; Strasser AA; Sofuoglu M; Kuzma A; Loughead J; Epperson CN
    Nicotine Tob Res; 2022 Nov; 24(12):1898-1905. PubMed ID: 35713950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
    Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
    Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
    Bozinoff N; Le Foll B
    Expert Rev Respir Med; 2018 Sep; 12(9):793-804. PubMed ID: 30092681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation.
    Roh S
    J Prev Med Public Health; 2018 Jan; 51(1):1-5. PubMed ID: 29397646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence.
    Baker TB; Piper ME; Schlam TR; Cook JW; Smith SS; Loh WY; Bolt D
    J Abnorm Psychol; 2012 Nov; 121(4):909-21. PubMed ID: 22642839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.